{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T21:09:19Z","timestamp":1782508159162,"version":"3.54.5"},"reference-count":114,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"CONACYT\/M\u00e9xico","award":["CB-2008-01"],"award-info":[{"award-number":["CB-2008-01"]}]},{"name":"CONACYT\/M\u00e9xico","award":["102109"],"award-info":[{"award-number":["102109"]}]},{"name":"CONACYT\/M\u00e9xico","award":["CB-2010-01"],"award-info":[{"award-number":["CB-2010-01"]}]},{"name":"CONACYT\/M\u00e9xico","award":["151818"],"award-info":[{"award-number":["151818"]}]},{"name":"CONACYT\/M\u00e9xico","award":["FAI\/UASLP\/2015"],"award-info":[{"award-number":["FAI\/UASLP\/2015"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.vaccine.2015.05.104","type":"journal-article","created":{"date-parts":[[2015,6,14]],"date-time":"2015-06-14T06:47:33Z","timestamp":1434264453000},"page":"3650-3658","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Chikungunya virus vaccines: Current strategies and prospects for developing plant-made vaccines"],"prefix":"10.1016","volume":"33","author":[{"given":"Jorge A.","family":"Salazar-Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Angulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Rosales-Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2015.05.104_bib0575","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF02030766","article-title":"A destructive arthropathy following Chikungunya virus arthritis\u2014a possible association","volume":"3","author":"Brighton","year":"1984","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.vaccine.2015.05.104_bib0580","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1017\/S0022172400044442","article-title":"The Newala epidemic. III. The virus: isolation, pathogenic properties and relationship to the epidemic","volume":"54","author":"Ross","year":"1956","journal-title":"J Hyg (London)"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0585","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/MMBR.58.3.491-562.1994","article-title":"The alphaviruses: gene expression, replication, and evolution","volume":"58","author":"Strauss","year":"1994","journal-title":"Microbiol Rev"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0590","series-title":"Fields\u2019 virology","first-page":"1001","article-title":"Togaviridae: the viruses and their replication","author":"Kuhn","year":"2007"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0595","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nature09555","article-title":"Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography","volume":"468","author":"Voss","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0600","first-page":"129","article-title":"An epidemic of dengue-like fever in Ceylon (chikungunya\u2014a clinical and haematological study)","volume":"11","author":"Munasinghe","year":"1966","journal-title":"Ceylon Med J"},{"issue":"491","key":"10.1016\/j.vaccine.2015.05.104_bib0605","article-title":"Disappearance of Chikungunya virus from India and South East Asia","volume":"80","author":"Pavri","year":"1986","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0610","first-page":"447","article-title":"Chikungunya infection\u2014an emerging disease in Malaysia","volume":"32","author":"Lam","year":"2001","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0615","doi-asserted-by":"crossref","first-page":"727","DOI":"10.4269\/ajtmh.2007.77.727","article-title":"A major epidemic of Chikungunya virus infection on Reunion Island, France, 2005\u20132006","volume":"77","author":"Renault","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0620","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.3201\/eid1812.120471","article-title":"Reemergence of Chikungunya virus in Cambodia","volume":"18","author":"Duong","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0625","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.3201\/eid1907.121563","article-title":"Reemergence of Chikungunya virus in Bo, Sierra Leone","volume":"19","author":"Ansumana","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0630","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(14)60185-9","article-title":"Chikungunya in the Americas","volume":"383","author":"Leparc-Goffart","year":"2014","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2015.05.104_bib0635","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.annemergmed.2014.08.002","article-title":"Update on emerging infections: news from the Centers for Disease Control and Prevention. Notes from the field: Chikungunya virus spreads in the Americas-Caribbean and South America, 2013\u20132014","volume":"64","author":"Fischer","year":"2014","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0640","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1371\/journal.ppat.0030201","article-title":"A single mutation in Chikungunya virus affects vector specificity and epidemic potential","volume":"3","author":"Tsetsarkin","year":"2007","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0645","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1371\/journal.pmed.0030263","article-title":"Genome microevolution of Chikungunya viruses causing the Indian Ocean outbreak","volume":"3","author":"Schuffenecker","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0650","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3855\/T2.2.140","article-title":"Ribavirin therapy for Chikungunya arthritis","volume":"2","author":"Ravichandran","year":"2008","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0655","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.antiviral.2003.09.005","article-title":"In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-alpha and ribavirin combination","volume":"61","author":"Briolant","year":"2004","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0660","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1089\/vbz.2008.0049","article-title":"On chikungunya acute infection and chloroquine treatment","volume":"8","author":"De Lamballerie","year":"2008","journal-title":"Vector Borne Zoonotic Dis"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0665","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/jmv.21663","article-title":"Assessment of in vitro prophylactic and therapeutic efficacy of chloroquine against Chikungunya virus in vero cells","volume":"82","author":"Khan","year":"2010","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0670","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1086\/600381","article-title":"Prophylaxis and therapy for Chikungunya virus infection","volume":"200","author":"Couderc","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0675","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/emmm.201200213","article-title":"Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein","volume":"4","author":"Kam","year":"2012","journal-title":"EMBO Mol Med"},{"issue":"Dec (23)","key":"10.1016\/j.vaccine.2015.05.104_bib0680","doi-asserted-by":"crossref","first-page":"13005","DOI":"10.1128\/JVI.01780-12","article-title":"Longitudinal analysis of the human antibody response to Chikungunya virus infection: implications for serodiagnosis and vaccine development","volume":"86","author":"Kam","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0685","doi-asserted-by":"crossref","first-page":"6295","DOI":"10.4049\/jimmunol.1300304","article-title":"An essential role of antibodies in the control of Chikungunya virus infection","volume":"190","author":"Lum","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0690","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1128\/AAC.17.6.1032","article-title":"Inhibition of herpes simplex virus multiplication by the pokeweed antiviral protein","volume":"17","author":"Aron","year":"1980","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0695","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.virusres.2012.10.032","article-title":"Inhibition of Japanese encephalitis virus infection in vitro and in vivo by pokeweed antiviral protein","volume":"171","author":"Ishag","year":"2013","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0700","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.antiviral.2014.05.019","article-title":"Inhibitory effects of a peptide-fusion protein (Latarcin-PAP1-Thanatin) against Chikungunya virus","volume":"108","author":"Rothan","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0705","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1371\/journal.ppat.0040029","article-title":"A mouse model for Chikungunya: young age and inefficient Type-I interferon signaling are risk factors for severe disease","volume":"4","author":"Couderc","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0710","doi-asserted-by":"crossref","first-page":"8021","DOI":"10.1128\/JVI.02603-09","article-title":"Chikungunya virus arthritis in adult wild-type mice","volume":"84","author":"Gardner","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0715","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ajpath.2010.11.018","article-title":"A mouse model of Chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence","volume":"178","author":"Morrison","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0720","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1172\/JCI40104","article-title":"Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages","volume":"120","author":"Labadie","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0725","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/infdis\/jiq042","article-title":"Persistent arthralgia induced by Chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor","volume":"203","author":"Chow","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0730","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1089\/vim.2009.0077","article-title":"Serum IL-18 and IL-18BP levels in patients with Chikungunya virus infection","volume":"23","author":"Chirathaworn","year":"2010","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0735","doi-asserted-by":"crossref","first-page":"5914","DOI":"10.4049\/jimmunol.0900255","article-title":"Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response","volume":"184","author":"Hoarau","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0740","doi-asserted-by":"crossref","first-page":"e1446","DOI":"10.1371\/journal.pntd.0001446","article-title":"Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia","volume":"6","author":"Dupuis-Maguiraga","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0745","doi-asserted-by":"crossref","first-page":"e2343","DOI":"10.1371\/journal.pntd.0002343","article-title":"Chikungunya virus infection results in higher and persistent viral replication in aged rhesus macaques due to defects in anti-viral immunity","volume":"7","author":"Messaoudi","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0750","doi-asserted-by":"crossref","first-page":"13878","DOI":"10.1128\/JVI.02666-13","article-title":"Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response","volume":"87","author":"Hawman","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0755","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1586\/erv.12.84","article-title":"Chikungunya virus and prospects for a vaccine","volume":"11","author":"Weaver","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0760","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nm.2105","article-title":"A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection","volume":"16","author":"Akahata","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0765","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1128\/AEM.23.5.951-952.1972","article-title":"Comparative immunogenicities of Chikungunya vaccines propagated in monkey kidney monolayers and chick embryo suspension cultures","volume":"23","author":"White","year":"1972","journal-title":"Appl Microbiol"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0770","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.1016\/j.vaccine.2012.07.072","article-title":"Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against Chikungunya virus","volume":"30","author":"Kumar","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0775","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0264-410X(86)90003-4","article-title":"Development of an attenuated strain of Chikungunya virus for use in vaccine production","volume":"4","author":"Levitt","year":"1986","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0780","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/514240","article-title":"Immunologic interference from sequential administration of live attenuated alphavirus vaccines","volume":"177","author":"McClain","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0785","doi-asserted-by":"crossref","first-page":"681","DOI":"10.4269\/ajtmh.2000.62.681","article-title":"Phase II safety and immunogenicity study of live Chikungunya virus vaccine TSI-GSD-218","volume":"62","author":"Edelman","year":"2000","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0790","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1016\/j.vaccine.2008.07.054","article-title":"Chimeric alphavirus vaccine candidates for chikungunya","volume":"26","author":"Wang","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0795","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1016\/j.vaccine.2011.01.108","article-title":"A complex adenovirus vaccine against Chikungunya virus provides complete protection against viraemia and arthritis","volume":"29","author":"Wang","year":"2011","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2015.05.104_bib0800","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.4269\/ajtmh.2011.11-0049","article-title":"Transmission potential of two chimeric Chikungunya vaccine candidates in the urban mosquito vectors, Aedes aegypti and Ae. albopictus","volume":"84","author":"Darwin","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0805","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1016\/j.vaccine.2008.03.060","article-title":"Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus","volume":"26","author":"Muthumani","year":"2008","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2015.05.104_bib0810","doi-asserted-by":"crossref","first-page":"e928","DOI":"10.1371\/journal.pntd.0000928","article-title":"A DNA vaccine against Chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates","volume":"5","author":"Mallilankaraman","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0815","doi-asserted-by":"crossref","first-page":"13333","DOI":"10.1128\/JVI.01926-14","article-title":"Prime-boost immunization strategies against Chikungunya virus","volume":"88","author":"Halleng\u00e4rd","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0820","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1128\/JVI.03453-13","article-title":"Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL\/6 mice","volume":"88","author":"Halleng\u00e4rd","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0825","first-page":"297","article-title":"Animal RNA virus expression systems","volume":"3","author":"Bredenbeek","year":"1992","journal-title":"Sem Virol"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0830","doi-asserted-by":"crossref","first-page":"11371","DOI":"10.1073\/pnas.93.21.11371","article-title":"Alphavirus-based expression vectors: strategies and applications","volume":"93","author":"Frolov","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0835","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/S0140-6736(14)61185-5","article-title":"Safety and tolerability of Chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial","volume":"384","author":"Chang","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0840","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1016\/j.vaccine.2013.05.086","article-title":"A recombinant measles vaccine expressing Chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with Chikungunya virus","volume":"31","author":"Brandler","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0845","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/1743-422X-8-353","article-title":"Functional processing and secretion of Chikungunya virus E1 and E2 glycoproteins in insect cells","volume":"8","author":"Metz","year":"2011","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0850","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.1016\/j.vaccine.2013.09.045","article-title":"Chikungunya virus-like particles are more immunogenic in a lethal AG129 mouse model compared to glycoprotein E1 or E2 subunits","volume":"31","author":"Metz","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0855","doi-asserted-by":"crossref","first-page":"e2124","DOI":"10.1371\/journal.pntd.0002124","article-title":"Effective Chikungunya virus-like particle vaccine produced in insect cells","volume":"7","author":"Metz","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0860","doi-asserted-by":"crossref","first-page":"e94401","DOI":"10.1371\/journal.pone.0094401","article-title":"Enhanced production of Chikungunya virus-like particles using a high-pH adapted spodoptera frugiperda insect cell line","volume":"9","author":"Wagner","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0865","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1016\/j.vaccine.2013.05.059","article-title":"Deciphering the protective role of adaptive immunity to CHIKV\/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model","volume":"31","author":"Chu","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0870","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1016\/j.vaccine.2011.01.076","article-title":"Probing the attenuation and protective efficacy of a candidate Chikungunya virus vaccine in mice with compromised interferon (IFN) signaling","volume":"29","author":"Partidos","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0875","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1128\/JVI.03418-13","article-title":"A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against Chikungunya infection","volume":"88","author":"Garc\u00eda-Arriaza","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0880","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.virusres.2012.05.004","article-title":"Subunit vaccine formulations based on recombinant envelope proteins of Chikungunya virus elicit balanced Th1\/Th2 response and virus-neutralizing antibodies in mice","volume":"167","author":"Khan","year":"2012","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0885","doi-asserted-by":"crossref","first-page":"e1002390","DOI":"10.1371\/journal.ppat.1002390","article-title":"Chikungunya virus neutralization antigens and direct cell-to-cell transmission are revealed by human antibody-escape mutants","volume":"7","author":"Lee","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0890","doi-asserted-by":"crossref","first-page":"14364","DOI":"10.1128\/JVI.01943-14","article-title":"Exposure of epitope residues on the outer face of the Chikungunya virus envelope trimer determines antibody neutralizing efficacy","volume":"88","author":"Fong","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0895","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.4269\/ajtmh.2010.10-0290","article-title":"Comparative pathogenesis of epidemic and enzootic Chikungunya virus in a pregnant Rhesus macaque model","volume":"83","author":"Chen","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0900","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1172\/JCI42392","article-title":"A nonhuman primate model of Chikungunya disease","volume":"120","author":"Higgs","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0905","doi-asserted-by":"crossref","first-page":"e95647","DOI":"10.1371\/journal.pone.0095647","article-title":"Unique epitopes recognized by antibodies induced in Chikungunya virus-infected non-human primates: implications for the study of immunopathology and vaccine development","volume":"9","author":"Kam","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0910","series-title":"Genetically engineered plants as a source of vaccines against wide spread diseases diseases\u2014an integrated view","first-page":"265","article-title":"Plant-based vaccines as a global vaccination approach: current perspectives","author":"Govea-Alonso","year":"2014"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0915","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4161\/hv.7.3.14207","article-title":"Clinical development of plant-produced recombinant pharmaceuticals: vaccines, antibodies and beyond","volume":"7","author":"Yusibov","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0920","series-title":"Genetically engineered plants as a source of vaccines against wide spread diseases\u2014an integrated view","first-page":"1","article-title":"Principles of plant-based vaccines","author":"Govea-Alonso","year":"2014"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0925","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11103-014-0279-5","article-title":"Current status of viral expression systems in plants and perspectives for oral vaccines development","volume":"87","author":"Salazar-Gonz\u00e1lez","year":"2015","journal-title":"Plant Mol Biol"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0930","series-title":"Genetically engineered plants as a source of vaccines against wide spread diseases diseases\u2014an integrated view","first-page":"15","article-title":"Mucosal immunology and oral vaccination","author":"Garc\u00eda-Hern\u00e1ndez","year":"2014"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0935","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/j.vaccine.2005.01.006","article-title":"Magnifection\u2014a new platform for expressing recombinant vaccines in plants","volume":"23","author":"Gleba","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0940","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1586\/erv.10.80","article-title":"In planta production of plant-derived and non-plant-derived adjuvants","volume":"9","author":"Granell","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0945","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.addr.2012.10.005","article-title":"Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells","volume":"Jun (65)","author":"Kwon","year":"2013","journal-title":"Adv Drug Delivery Rev"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0950","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1586\/erv.12.147","article-title":"Virus-like particles produced in plants as potential vaccines","volume":"12","author":"Scotti","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0955","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.vaccine.2015.02.036","article-title":"Novel vaccination approach for dengue infection based on recombinant immune complex universal platform","volume":"33","author":"Kim","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0960","first-page":"919","article-title":"Cholera toxin B subunit modulation of mucosal vaccines for infectious and autoimmune diseases","volume":"11","author":"Langridge","year":"2010","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0965","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/mt.2013.273","article-title":"Oral delivery of bioencapsulated proteins across blood\u2013brain and blood\u2013retinal barriers","volume":"22","author":"Kohli","year":"2014","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0970","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.tplants.2009.09.009","article-title":"Plant-made vaccine antigens and biopharmaceuticals","volume":"14","author":"Daniell","year":"2009","journal-title":"Trends Plant Sci"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0975","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nm0598-607","article-title":"Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato","volume":"4","author":"Tacket","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0980","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1467-7652.2009.00497.x","article-title":"Plant-specific glycosylation patterns in the context of therapeutic protein production","volume":"8","author":"Gomord","year":"2010","journal-title":"Plant Biotechnol J"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0985","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1042\/BJ20041686","article-title":"Molecular basis of N-acetylglucosaminyltransferase I deficiency in Arabidopsis thaliana plants lacking complex N-glycans","volume":"387","author":"Strasser","year":"2005","journal-title":"Biochem J"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0990","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1467-7652.2007.00273.x","article-title":"Production of a monoclonalantibody in plants with a humanized N-glycosylation pattern","volume":"5","author":"Sch\u00e4hs","year":"2007","journal-title":"Plant Biotechnol J"},{"key":"10.1016\/j.vaccine.2015.05.104_bib0995","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.pbi.2004.01.015","article-title":"Posttranslational modification of therapeutic proteins in plants","volume":"7","author":"Gomord","year":"2004","journal-title":"Curr Opin Plant Biol"},{"key":"10.1016\/j.vaccine.2015.05.104_bib1000","doi-asserted-by":"crossref","first-page":"822","DOI":"10.4049\/jimmunol.107.3.822","article-title":"Early and enhanced germinal center formation and antibody responses in mice after primary stimulation with antigen-isologous antibody complexes as compared with antigen alone","volume":"107","author":"Laissue","year":"1971","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.05.104_bib1005","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1002\/eji.1830271253","article-title":"Immunization with immune complex alters the repertoire of antigen-reactive B cells in the germinal centers","volume":"27","author":"Nie","year":"1997","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2015.05.104_bib1010","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1084\/jem.189.2.371","article-title":"Fc gamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization","volume":"189","author":"Regnault","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2015.05.104_bib1015","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.4049\/jimmunol.168.5.2240","article-title":"Antigen-antibody immune complexes empower dendritic cells to efficiently prime specific CD8+ CTL responses in vivo","volume":"168","author":"Schuurhuis","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.05.104_bib1020","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/0167-5699(90)90126-T","article-title":"The immune complex: possible ways of regulating the antibody response","volume":"11","author":"Heyman","year":"1990","journal-title":"Immunol Today"},{"key":"10.1016\/j.vaccine.2015.05.104_bib1025","doi-asserted-by":"crossref","first-page":"5915","DOI":"10.1128\/IAI.73.9.5915-5922.2005","article-title":"Highly immunogenic and protective recombinant vaccine candidate expressed in transgenic plants","volume":"73","author":"Chargelegue","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.05.104_bib1030","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/pbi.12185","article-title":"Plant-derived recombinant immune complexes as self-adjuvanting TB immunogens for mucosal boosting of BCG","volume":"12","author":"Pepponi","year":"2014","journal-title":"Plant Biotechnol J"},{"key":"10.1016\/j.vaccine.2015.05.104_bib1035","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1467-7652.2011.00593.x","article-title":"Expression of an immunogenic Ebola immune complex in Nicotiana benthamiana","volume":"9","author":"Phoolcharoen","year":"2011","journal-title":"Plant Biotechnol J"},{"key":"10.1016\/j.vaccine.2015.05.104_bib1040","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1385\/MB:20:1:029","article-title":"Large-scale extraction of proteins","volume":"20","author":"Cunha","year":"2002","journal-title":"Mol Biotechnol"},{"key":"10.1016\/j.vaccine.2015.05.104_bib1045","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.tibtech.2009.10.004","article-title":"Elastin-like polypeptides revolutionize protein expression and their biomedical application","volume":"28","author":"Floss","year":"2010","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.vaccine.2015.05.104_bib1050","first-page":"2010","article-title":"Expression and immunogenicity of the mycobacterial Ag85B\/ESAT-6 antigens produced in transgenic plants by elastin-like peptide fusion strategy","volume":"13","author":"Floss","year":"2010","journal-title":"Biomed Biotechnol"},{"key":"10.1016\/j.vaccine.2015.05.104_bib1055","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/pbi.12049","article-title":"ELPylated haemagglutinins produced in tobacco plants induce potentially neutralizing antibodies against H5N1 viruses in mice","volume":"11","author":"Phan","year":"2013","journal-title":"Plant Biotechnol J"},{"key":"10.1016\/j.vaccine.2015.05.104_bib1060","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s12033-015-9856-3","article-title":"A plant-derived multi-HIV antigen induces broad immune responses in orally immunized mice","volume":"57","author":"Rubio-Infante","year":"2015","journal-title":"Mol Biotechnol"},{"key":"10.1016\/j.vaccine.2015.05.104_bib1065","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00425-013-1932-y","article-title":"Immunogenic properties of a lettuce-derived C4(V3)6 multiepitopic HIV protein","volume":"238","author":"Govea-Alonso","year":"2013","journal-title":"Planta"},{"key":"10.1016\/j.vaccine.2015.05.104_bib1070","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s12033-015-9853-6","article-title":"Expression of multiple Taenia solium immunogens in plant cells through a ribosomal skip mechanism","volume":"57","author":"Monreal-Escalante","year":"2015","journal-title":"Mol Biotechnol"},{"key":"10.1016\/j.vaccine.2015.05.104_bib1075","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/89297","article-title":"A plant-based multicomponent vaccine protects mice from enteric diseases","volume":"19","author":"Yu","year":"2001","journal-title":"Nat Biotechnol"},{"issue":"Nov (49)","key":"10.1016\/j.vaccine.2015.05.104_bib1080","doi-asserted-by":"crossref","first-page":"6711","DOI":"10.1016\/j.vaccine.2014.08.089","article-title":"The mucosal immune system for vaccine development","volume":"32","author":"Lamichhane","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.104_bib1085","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1586\/14760584.2014.913483","article-title":"Immunological aspects of using plant cells as delivery vehicles for oral vaccines","volume":"13","author":"Rosales-Mendoza","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2015.05.104_bib1090","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.2174\/138920112804724837","article-title":"Is an oral plant-based vaccine against hepatitis B virus possible","volume":"13","author":"Pniewski","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"issue":"86","key":"10.1016\/j.vaccine.2015.05.104_bib1095","first-page":"e51204","article-title":"Optimization and utilization of Agrobacterium-mediated transient protein production in Nicotiana","volume":"19","author":"Shamloul","year":"2014","journal-title":"J Vis Exp"},{"issue":"Dec (6)","key":"10.1016\/j.vaccine.2015.05.104_bib1100","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1177\/2211068212460037","article-title":"Automated production of plant-based vaccines and pharmaceuticals","volume":"17","author":"Wirz","year":"2012","journal-title":"J Lab Autom"},{"issue":"4","key":"10.1016\/j.vaccine.2015.05.104_bib1105","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1586\/14760584.2015.989988","article-title":"Advances and challenges in the development and production of effective plant-based influenza vaccines","volume":"14","author":"Yusibov","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2015.05.104_bib1110","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4161\/hv.34365","article-title":"Immunogenicity of H1N1 influenza virus-like particles produced in Nicotiana benthamiana","volume":"11","author":"Shoji","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2015.05.104_bib1115","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.clim.2014.08.003","article-title":"Influenza virus-like particle vaccines made in Nicotiana benthamiana elicit durable, poly-functional and cross-reactive T cell responses to influenza HA antigens","volume":"154","author":"Landry","year":"2014","journal-title":"Clin Immunol"},{"key":"10.1016\/j.vaccine.2015.05.104_bib1120","first-page":"3","article-title":"Plant nuclear transformation","volume":"vol. 64","author":"Finer","year":"2010"},{"issue":"3","key":"10.1016\/j.vaccine.2015.05.104_bib1125","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2174\/187220808786241033","article-title":"Agrobacterium-mediated transient expression as an approach to production of recombinant proteins in plants","volume":"2","author":"Sheludko","year":"2008","journal-title":"Recent Pat Biotechnol"},{"key":"10.1016\/j.vaccine.2015.05.104_bib1130","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1104\/pp.107.106690","article-title":"Chloroplast vector systems for biotechnology applications","volume":"145","author":"Verma","year":"2007","journal-title":"Plant Physiol"},{"key":"10.1016\/j.vaccine.2015.05.104_bib1135","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1467-7652.2008.00381.x","article-title":"Biochemical and immunological characterization of the plant-derived candidate human immunodeficiency virus type 1 mucosal vaccine CTB-MPR","volume":"7","author":"Matoba","year":"2009","journal-title":"Plant Biotechnol J"},{"key":"10.1016\/j.vaccine.2015.05.104_bib1140","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12985-014-0205-0","article-title":"Plant-based vaccines against viruses","volume":"11","author":"Rybicki","year":"2014","journal-title":"Virol J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15007938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15007938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T12:12:19Z","timestamp":1691755939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15007938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":114,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0264410X15007938"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.05.104","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chikungunya virus vaccines: Current strategies and prospects for developing plant-made vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.05.104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}